Immunohistochemical Expression of Estrogen Receptor Beta in Urothelial Carcinoma of the Urinary Bladder
Badawy, O., Mohamed, S., Hassan, A., Mohamed, G. (2023). Immunohistochemical Expression of Estrogen Receptor Beta in Urothelial Carcinoma of the Urinary Bladder. EKB Journal Management System, 6(2), 241-248. doi: 10.21608/svuijm.2022.160639.1403
Omnia M.M. Badawy; Sabah Ahmed Mohamed; Ahmed Mahmoud Hassan; Ghada Hosny Mohamed. "Immunohistochemical Expression of Estrogen Receptor Beta in Urothelial Carcinoma of the Urinary Bladder". EKB Journal Management System, 6, 2, 2023, 241-248. doi: 10.21608/svuijm.2022.160639.1403
Badawy, O., Mohamed, S., Hassan, A., Mohamed, G. (2023). 'Immunohistochemical Expression of Estrogen Receptor Beta in Urothelial Carcinoma of the Urinary Bladder', EKB Journal Management System, 6(2), pp. 241-248. doi: 10.21608/svuijm.2022.160639.1403
Badawy, O., Mohamed, S., Hassan, A., Mohamed, G. Immunohistochemical Expression of Estrogen Receptor Beta in Urothelial Carcinoma of the Urinary Bladder. EKB Journal Management System, 2023; 6(2): 241-248. doi: 10.21608/svuijm.2022.160639.1403

Immunohistochemical Expression of Estrogen Receptor Beta in Urothelial Carcinoma of the Urinary Bladder

SVU-International Journal of Medical Sciences
Article 22, Volume 6, Issue 2, July 2023, Page 241-248  XML PDF (405.38 K)
Document Type: Original research articles
DOI: 10.21608/svuijm.2022.160639.1403
View on SCiNiTO View on SCiNiTO
Authors
Omnia M.M. Badawy email 1; Sabah Ahmed Mohamed2; Ahmed Mahmoud Hassan3; Ghada Hosny Mohamed2
1Pathology Department, Faculty of Medicine, South Valley University, Qena, Egypt.
2Pathology Department, Faculty of Medicine, Assiut University, Assiut, Egypt.
3Urology Department, Faculty of Medicine, South Valley University, Qena, Egypt.
Abstract
Background: The tenth most prevalent cancer type in the world is bladder cancer. Males are four times more likely than females to have it. The most prevalent subtype is urothelial carcinoma. Development and progression of bladder cancer are influenced by estrogen receptors.
Objectives: To examine the expression of estrogen receptor beta in bladder urothelial carcinoma and how it relates to other pathological factors of prognostic significance.
Materials and method: Fifty formalin fixed and paraffin-embedded tissue sections of cases of urothelial carcinoma from transurethral resection and radical cystectomy specimens were examined histopathologically by routine H&E stain and immunohistochemically stained with Anti-ER-beta antibody. The immunohistochemical expression of estrogen receptor beta was assessed.
Results: Of the 50 cases of urothelial carcinoma, mean age 60 ±8.7 range (41-85) years, 34 male and 16 female, estrogen receptor beta was expressed in 29 (58%) of the cases. The expression of ERβ was significantly elevated in high grade (p value 0.006). The ERβ expression was also significantly increased in advanced tumor stages (p value 0.03) and in muscle invasive tumor (p value 0.004). The presence of lymphovascular emboli was associated with higher ERβexpression.
Conclusion: ERβ expression is significantly associated with high grade and with advanced stages of urothelial carcinoma.
Keywords
Estrogen receptor beta; Immunohistochemistry; Urothelial carcinoma; Urinary bladder
Statistics
Article View: 202
PDF Download: 186